Heterogeneity of health status treatment response with sacubitril/valsartan: insights from the CHAMP‐HF registry

AIMS: The aim of our study was to investigate heterogeneity of health status treatment response of sacubitril/valsartan in patients with heart failure with reduced ejection fraction (HFrEF). METHODS AND RESULTS: We leveraged data from CHAMP‐HF, an observational registry of 140 US clinics and 5026 ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Khariton, Yevgeniy, Fonarow, Gregg C., Hellkamp, Ann, Thomas, Laine, Nassif, Michael E., Butler, Javed, Duffy, Carol I., Albert, Nancy M., Spertus, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835503/
https://www.ncbi.nlm.nih.gov/pubmed/33170559
http://dx.doi.org/10.1002/ehf2.12981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835503/
https://www.ncbi.nlm.nih.gov/pubmed/33170559
http://dx.doi.org/10.1002/ehf2.12981

Ejemplares similares